首页 > 最新文献

Journal of Patient-Centered Research and Reviews最新文献

英文 中文
A Message to Our 2022 Peer Reviewers: Thank You 致2022年同行评审员的一封信:谢谢
IF 1.7 Q3 HEALTH CARE SCIENCES & SERVICES Pub Date : 2023-01-17 DOI: 10.17294/2330-0698.2034
{"title":"A Message to Our 2022 Peer Reviewers: Thank You","authors":"","doi":"10.17294/2330-0698.2034","DOIUrl":"https://doi.org/10.17294/2330-0698.2034","url":null,"abstract":"","PeriodicalId":16724,"journal":{"name":"Journal of Patient-Centered Research and Reviews","volume":"1 1","pages":""},"PeriodicalIF":1.7,"publicationDate":"2023-01-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49656310","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Attitudes Toward Personal Health Data Sharing Among People Living With Sickle Cell Disorder, Exemplar for Study of Rare Disease Populations. 镰状细胞病患者对个人健康数据共享的态度,罕见疾病人群研究的范例。
IF 1.7 Q3 HEALTH CARE SCIENCES & SERVICES Pub Date : 2023-01-01 DOI: 10.17294/2330-0698.2006
Rebecca Baines, Sebastian Stevens, Zainab Garba-Sani, Arunangsu Chatterjee, Daniela Austin, Simon Leigh

Purpose: Rare conditions are often poorly understood, creating barriers in determining the value treatments can provide. This study explored barriers and facilitators to personal health data sharing among those with one particular group of rare hematologic disorders, ie, sickle cell disorder (SCD) and its variants.

Methods: A single online focus group among those >18 years of age and living with SCD was conducted. Participants (N=25) were recruited through a United Kingdom-based SCD charity. Discussions were transcribed verbatim, with data therein analyzed using inductive thematic analysis.

Results: Five primary motivators for sharing health data were identified: improving awareness; knowing this would help others; evidencing impact; financial incentives; and being recognized as "experts with lived experience" rather than "specimens to be studied." Barriers included lack of clarity regarding "why" data was sought and "who" benefited. Participants stated that electronic health record (EHR) and genetic data were often "too detailed" and therefore "off limits" for sharing. However, experiences, mindset, and well-being data, often hidden from the EHR, were acceptable to share and considered a better barometer of how rare conditions treat patients day-to-day.

Conclusions: Utilizing patient experience data obtained under real-world conditions is key to painting the most accurate picture of needs and understanding how SCD impacts patients' day-to-day lives. Study findings suggest that patients with SCD are not merely passive providers of health data, but rather experts by experience. To appreciate the value that patient perspectives bring, we must revisit this status quo, amending our approach to patient centricity and reframing patients as high-value managers of their condition and personal health data who crucially decide what, how, and when they share it.

目的:罕见的情况往往是知之甚少,在确定价值治疗可以提供的障碍。本研究探讨了一组罕见血液病,即镰状细胞病(SCD)及其变体患者之间个人健康数据共享的障碍和促进因素。方法:对年龄>18岁的SCD患者进行单一在线焦点小组调查。参与者(N=25)是通过一家总部位于英国的SCD慈善机构招募的。讨论内容逐字记录下来,其中的数据用归纳专题分析加以分析。结果:确定了共享健康数据的五个主要动机:提高认识;知道这一点会帮助别人;列明的影响;财政激励措施;被认为是“有经验的专家”,而不是“需要研究的样本”。障碍包括对“为什么”寻求数据和“谁”受益缺乏明确性。与会者指出,电子健康记录和遗传数据往往"过于详细",因此"禁止"分享。然而,通常隐藏在EHR之外的经验,心态和健康数据是可以接受的,并且被认为是罕见疾病如何治疗患者日常的更好的晴雨表。结论:利用在现实条件下获得的患者经验数据是描绘最准确的需求图景和了解SCD如何影响患者日常生活的关键。研究结果表明,SCD患者不仅仅是健康数据的被动提供者,而是经验丰富的专家。为了欣赏患者观点带来的价值,我们必须重新审视这种现状,修改我们以患者为中心的方法,并将患者重新定义为他们的病情和个人健康数据的高价值管理者,他们至关重要地决定他们分享什么、如何以及何时分享这些数据。
{"title":"Attitudes Toward Personal Health Data Sharing Among People Living With Sickle Cell Disorder, Exemplar for Study of Rare Disease Populations.","authors":"Rebecca Baines,&nbsp;Sebastian Stevens,&nbsp;Zainab Garba-Sani,&nbsp;Arunangsu Chatterjee,&nbsp;Daniela Austin,&nbsp;Simon Leigh","doi":"10.17294/2330-0698.2006","DOIUrl":"https://doi.org/10.17294/2330-0698.2006","url":null,"abstract":"<p><strong>Purpose: </strong>Rare conditions are often poorly understood, creating barriers in determining the value treatments can provide. This study explored barriers and facilitators to personal health data sharing among those with one particular group of rare hematologic disorders, ie, sickle cell disorder (SCD) and its variants.</p><p><strong>Methods: </strong>A single online focus group among those >18 years of age and living with SCD was conducted. Participants (N=25) were recruited through a United Kingdom-based SCD charity. Discussions were transcribed verbatim, with data therein analyzed using inductive thematic analysis.</p><p><strong>Results: </strong>Five primary motivators for sharing health data were identified: improving awareness; knowing this would help others; evidencing impact; financial incentives; and being recognized as \"experts with lived experience\" rather than \"specimens to be studied.\" Barriers included lack of clarity regarding \"why\" data was sought and \"who\" benefited. Participants stated that electronic health record (EHR) and genetic data were often \"too detailed\" and therefore \"off limits\" for sharing. However, experiences, mindset, and well-being data, often hidden from the EHR, were acceptable to share and considered a better barometer of how rare conditions treat patients day-to-day.</p><p><strong>Conclusions: </strong>Utilizing patient experience data obtained under real-world conditions is key to painting the most accurate picture of needs and understanding how SCD impacts patients' day-to-day lives. Study findings suggest that patients with SCD are not merely passive providers of health data, but rather experts by experience. To appreciate the value that patient perspectives bring, we must revisit this status quo, amending our approach to patient centricity and reframing patients as high-value managers of their condition and personal health data who crucially decide what, how, and when they share it.</p>","PeriodicalId":16724,"journal":{"name":"Journal of Patient-Centered Research and Reviews","volume":"10 2","pages":"68-76"},"PeriodicalIF":1.7,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10117534/pdf/jpcrr-10.2.68.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9381859","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Examining Racial Disparities in Unemployment Among Health Care Workers Before, During, and After the COVID-19 Pandemic. 研究在COVID-19大流行之前,期间和之后医疗工作者失业的种族差异。
IF 1.7 Q3 HEALTH CARE SCIENCES & SERVICES Pub Date : 2023-01-01 DOI: 10.17294/2330-0698.2021
Jason Semprini

Among the U.S. health care workforce, the COVID-19 pandemic appeared to greatly impact employment levels in 2020. However, no research has examined how the pandemic's impact on employment varied by racial/ethnic group or beyond the initial emergency year. Our study aimed to quantitatively evaluate workforce trends by race/ethnicity before, during, and after the COVID-19 pandemic. This study analyzed each March supplement of the Current Population Survey over a 5-year span (2018-2022). We restricted the sample to nurses, physician assistants, and other non-physician health care workers (HCW), per specific census occupation codes, and constructed an event-history study to test for differential effects from each year, as compared to 2019, on the proportion of employment between non-Hispanic White, non-Hispanic Black, Hispanic, non-Hispanic Native (American Indian, Alaska Native, Hawaiian Islander), and non-Hispanic Asian HCW. Results suggest that the pandemic's negative impact on the health care workforce disproportionately reduced employment for HCW self-identifying as Black or Indigenous. Rates for other groups increased 2-3 percentage points in 2020 but returned to prepandemic levels by 2022. However, for Black and Native HCW, the change was twice as large in 2021 and remained significantly higher in 2022 for Black HCW, providing more evidence that the burden of the COVID-19 pandemic disproportionately fell on people of color. Future research investigating how employment disruptions impacted the health care workforce and, potentially, health equity remains warranted.

在美国医疗保健工作者中,2019冠状病毒病大流行似乎对2020年的就业水平产生了重大影响。然而,没有一项研究审查大流行病对就业的影响如何因种族/族裔群体而异,或在最初的紧急年份之后。我们的研究旨在定量评估COVID-19大流行之前、期间和之后按种族/民族划分的劳动力趋势。本研究分析了5年(2018-2022年)期间《当前人口调查》每年3月份的增刊。我们将样本限制为护士、医师助理和其他非医师卫生保健工作者(HCW),根据特定的人口普查职业代码,并构建了一项事件历史研究,以测试与2019年相比,每年对非西班牙裔白人、非西班牙裔黑人、西班牙裔、非西班牙裔原住民(美洲印第安人、阿拉斯加原住民、夏威夷岛民)和非西班牙裔亚裔卫生保健工作者就业比例的差异影响。结果表明,大流行对卫生保健人力的负面影响不成比例地减少了自认为是黑人或土著的HCW的就业。其他群体的发病率在2020年上升了2-3个百分点,但到2022年恢复到大流行前的水平。然而,对于黑人和土著HCW来说,这一变化在2021年是其两倍,在2022年黑人HCW的变化仍然高得多,这提供了更多证据,证明COVID-19大流行的负担不成比例地落在了有色人种身上。未来的研究将调查就业中断如何影响卫生保健工作人员,并可能影响卫生公平。
{"title":"Examining Racial Disparities in Unemployment Among Health Care Workers Before, During, and After the COVID-19 Pandemic.","authors":"Jason Semprini","doi":"10.17294/2330-0698.2021","DOIUrl":"https://doi.org/10.17294/2330-0698.2021","url":null,"abstract":"<p><p>Among the U.S. health care workforce, the COVID-19 pandemic appeared to greatly impact employment levels in 2020. However, no research has examined how the pandemic's impact on employment varied by racial/ethnic group or beyond the initial emergency year. Our study aimed to quantitatively evaluate workforce trends by race/ethnicity before, during, and after the COVID-19 pandemic. This study analyzed each March supplement of the Current Population Survey over a 5-year span (2018-2022). We restricted the sample to nurses, physician assistants, and other non-physician health care workers (HCW), per specific census occupation codes, and constructed an event-history study to test for differential effects from each year, as compared to 2019, on the proportion of employment between non-Hispanic White, non-Hispanic Black, Hispanic, non-Hispanic Native (American Indian, Alaska Native, Hawaiian Islander), and non-Hispanic Asian HCW. Results suggest that the pandemic's negative impact on the health care workforce disproportionately reduced employment for HCW self-identifying as Black or Indigenous. Rates for other groups increased 2-3 percentage points in 2020 but returned to prepandemic levels by 2022. However, for Black and Native HCW, the change was twice as large in 2021 and remained significantly higher in 2022 for Black HCW, providing more evidence that the burden of the COVID-19 pandemic disproportionately fell on people of color. Future research investigating how employment disruptions impacted the health care workforce and, potentially, health equity remains warranted.</p>","PeriodicalId":16724,"journal":{"name":"Journal of Patient-Centered Research and Reviews","volume":"10 3","pages":"136-141"},"PeriodicalIF":1.7,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10358973/pdf/jpcrr-10.3.136.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10240547","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Interpreting P Values in 2023. 解读2023年的P值。
IF 1.7 Q3 HEALTH CARE SCIENCES & SERVICES Pub Date : 2023-01-01 DOI: 10.17294/2330-0698.2064
Jennifer K Homa-Bonell
{"title":"Interpreting <i>P</i> Values in 2023.","authors":"Jennifer K Homa-Bonell","doi":"10.17294/2330-0698.2064","DOIUrl":"https://doi.org/10.17294/2330-0698.2064","url":null,"abstract":"","PeriodicalId":16724,"journal":{"name":"Journal of Patient-Centered Research and Reviews","volume":"10 3","pages":"102-103"},"PeriodicalIF":1.7,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10358974/pdf/jpcrr-10.3.102.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9863441","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
COVID-19 Proactive Disease Management Using COVID Virtual Hospital in a Rural Community. 在农村社区使用COVID虚拟医院进行COVID-19主动疾病管理。
IF 1.7 Q3 HEALTH CARE SCIENCES & SERVICES Pub Date : 2023-01-01 DOI: 10.17294/2330-0698.1998
Gandhari Loomis, Regina Rhodes, Ed Bujold, Golnosh Sharafsaleh, Ellen Collett, Mark Irwin, Elizabeth W Staton, John M Westfall

Purpose: A community teaching hospital serving a rural population established an intensive "hospital at home" program for patients with COVID-19 utilizing disease risk stratification and pulse oximeter readings to dictate nurse and clinician contact. Herein, we report patient outcomes and provider experiences resulting from this "virtual" approach to triaging pandemic care.

Methods: COVID-19-positive patients appropriate for outpatient management were enrolled in our COVID Virtual Hospital (CVH). Patients received pulse oximeters and instructions for home monitoring of vital signs. CVH nurses contacted the patient within 12-48 hours. The primary care provider was alerted of the patient's diagnosis and held a virtual visit with patient within 2-3 days. Nurses completed a triage form during each patient call; the resulting risk score determined timing of subsequent calls. CVH-relevant patient outcomes included emergency department (ED) visits, mortality, and disease-related hospitalization. Additionally, a survey of providers was conducted to assess CVH experience.

Results: From April 22, 2020, to December 21, 2020, 1916 patients were enrolled in the CVH, of which 195 (10.2%) had subsequent visits to the ED. Among those 195 ED visits, 102 (52.3%) were nurse-directed while 93 (47.7%) were patient self-directed; 88 (86.3%) nurse-directed ED visits were subsequently admitted to inpatient care and 14 were discharged home. Of the 93 self-directed ED visits, 3 (3.2%) were admitted. A total of 91 CVH patients (4.7%) were ultimately admitted to inpatient care. Seven deaths occurred among CVH patients, 5 of whom had been admitted for inpatient care. Among 71 providers (23%) who responded to the survey, 94% and 93% agreed that the CVH was beneficial to providers and patients, respectively.

Conclusions: Proactive in-home triage of patients with COVID-19 utilizing a virtual hospital model minimized unnecessary presentations to ED and likely prevented our rural hospital from becoming overwhelmed during year one of the pandemic.

目的:一家为农村人口服务的社区教学医院为COVID-19患者建立了一个强化的“家庭医院”项目,利用疾病风险分层和脉搏血氧仪读数来指示护士和临床医生的联系方式。在此,我们报告了这种“虚拟”方法对流行病护理进行分诊的患者结果和提供者经验。方法:将适合门诊管理的COVID-19阳性患者纳入我们的COVID虚拟医院(CVH)。患者接受脉搏血氧仪和家庭生命体征监测指导。CVH护士在12-48小时内联系了患者。初级保健提供者被告知患者的诊断,并在2-3天内与患者进行了虚拟访问。护士在每个病人就诊时填写一份分诊表;由此产生的风险评分决定了后续调用的时间。cvh相关的患者结果包括急诊就诊、死亡率和疾病相关住院。此外,对供应商进行了一项调查,以评估CVH的经验。结果:2020年4月22日至2020年12月21日,共有1916例患者入组CVH,其中195例(10.2%)患者随访急诊科,其中102例(52.3%)患者在护士指导下就诊,93例(47.7%)患者自行就诊;88例(86.3%)在护士指导下急诊科就诊,随后住院治疗,14例出院回家。在93例自行诊症中,3例(3.2%)获接纳。共有91例CVH患者(4.7%)最终住院治疗。CVH患者中有7例死亡,其中5例入院接受住院治疗。在接受调查的71名提供者(23%)中,分别有94%和93%的人同意CVH对提供者和患者有益。结论:利用虚拟医院模型对COVID-19患者进行主动在家分诊,最大限度地减少了不必要的急诊科就诊,并有可能防止我们的农村医院在大流行的第一年不堪重负。
{"title":"COVID-19 Proactive Disease Management Using COVID Virtual Hospital in a Rural Community.","authors":"Gandhari Loomis,&nbsp;Regina Rhodes,&nbsp;Ed Bujold,&nbsp;Golnosh Sharafsaleh,&nbsp;Ellen Collett,&nbsp;Mark Irwin,&nbsp;Elizabeth W Staton,&nbsp;John M Westfall","doi":"10.17294/2330-0698.1998","DOIUrl":"https://doi.org/10.17294/2330-0698.1998","url":null,"abstract":"<p><strong>Purpose: </strong>A community teaching hospital serving a rural population established an intensive \"hospital at home\" program for patients with COVID-19 utilizing disease risk stratification and pulse oximeter readings to dictate nurse and clinician contact. Herein, we report patient outcomes and provider experiences resulting from this \"virtual\" approach to triaging pandemic care.</p><p><strong>Methods: </strong>COVID-19-positive patients appropriate for outpatient management were enrolled in our COVID Virtual Hospital (CVH). Patients received pulse oximeters and instructions for home monitoring of vital signs. CVH nurses contacted the patient within 12-48 hours. The primary care provider was alerted of the patient's diagnosis and held a virtual visit with patient within 2-3 days. Nurses completed a triage form during each patient call; the resulting risk score determined timing of subsequent calls. CVH-relevant patient outcomes included emergency department (ED) visits, mortality, and disease-related hospitalization. Additionally, a survey of providers was conducted to assess CVH experience.</p><p><strong>Results: </strong>From April 22, 2020, to December 21, 2020, 1916 patients were enrolled in the CVH, of which 195 (10.2%) had subsequent visits to the ED. Among those 195 ED visits, 102 (52.3%) were nurse-directed while 93 (47.7%) were patient self-directed; 88 (86.3%) nurse-directed ED visits were subsequently admitted to inpatient care and 14 were discharged home. Of the 93 self-directed ED visits, 3 (3.2%) were admitted. A total of 91 CVH patients (4.7%) were ultimately admitted to inpatient care. Seven deaths occurred among CVH patients, 5 of whom had been admitted for inpatient care. Among 71 providers (23%) who responded to the survey, 94% and 93% agreed that the CVH was beneficial to providers and patients, respectively.</p><p><strong>Conclusions: </strong>Proactive in-home triage of patients with COVID-19 utilizing a virtual hospital model minimized unnecessary presentations to ED and likely prevented our rural hospital from becoming overwhelmed during year one of the pandemic.</p>","PeriodicalId":16724,"journal":{"name":"Journal of Patient-Centered Research and Reviews","volume":"10 3","pages":"104-110"},"PeriodicalIF":1.7,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10358976/pdf/jpcrr-10.3.104.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9863442","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Perspectives of People With Cancer or Hereditary Cancer Risk on the Use and Value of Online Peer Support. 癌症或遗传癌症风险人群对在线同伴支持的使用和价值的看法。
IF 1.7 Q3 HEALTH CARE SCIENCES & SERVICES Pub Date : 2023-01-01 DOI: 10.17294/2330-0698.1968
Jill Holdren, Karl Surkan, Andrea Downing

Purpose: People with cancer routinely seek information and support in peer groups online. While peer communities constitute a major component of the health care landscape, they exist in isolation from clinical and research institutions. This study aimed to explore how and why cancer patients utilize online peer support groups and how they might be improved.

Methods: A convenience sample of members of 6 closed Facebook cancer peer support groups (n=291) participated in an online needs assessment survey. We further conducted semi-structured interviews with 14 members and 6 moderator-patients, hand-coding the free-text responses and interview transcripts.

Results: Group participation was largely motivated by the desire to exchange information (79%) and to connect with others sharing the same condition (76%). Among study participants, 40% indicated they did not get information or support from any other online or offline organizations, 60% indicated they had few concerns with Facebook peer support groups, 84% indicated it was at least somewhat important that their health information and posts remain private, and 75% desired more input from experts in order to access evidence-based information and curb misinformation. About half wanted more group moderation, and moderators themselves expressed an urgent need for training and support.

Conclusions: While online peer groups are a commonly utilized care component for many people with cancer or hereditary cancer risk and serve as a primary source of condition information, many participants desired more expert involvement in and moderation of groups. Privacy and security of health information was another key need expressed.

目的:癌症患者通常会在网上的同伴群体中寻求信息和支持。虽然同侪社区是保健领域的一个重要组成部分,但它们与临床和研究机构是隔离存在的。这项研究旨在探索癌症患者如何以及为什么利用在线同伴支持小组,以及如何改进他们。方法:选取6个封闭的Facebook癌症同伴支持小组的方便样本(n=291)参与在线需求评估调查。我们进一步对14名成员和6名主持患者进行了半结构化访谈,并对自由文本回答和访谈记录进行了手工编码。结果:小组参与的主要动机是交换信息(79%)和与其他有相同条件的人联系(76%)。在研究参与者中,40%的人表示他们没有从任何其他在线或离线组织获得信息或支持,60%的人表示他们很少担心Facebook的同伴支持小组,84%的人表示他们的健康信息和帖子保持隐私至少有点重要,75%的人希望从专家那里获得更多的信息,以便获得基于证据的信息并遏制错误信息。大约一半的人想要更多的小组审核,审核人自己也表示迫切需要培训和支持。结论:虽然在线同伴小组是许多有癌症或遗传性癌症风险的人通常使用的护理组成部分,并作为病情信息的主要来源,但许多参与者希望更多的专家参与和适度的小组。健康信息的隐私和安全是另一项重要需求。
{"title":"Perspectives of People With Cancer or Hereditary Cancer Risk on the Use and Value of Online Peer Support.","authors":"Jill Holdren,&nbsp;Karl Surkan,&nbsp;Andrea Downing","doi":"10.17294/2330-0698.1968","DOIUrl":"https://doi.org/10.17294/2330-0698.1968","url":null,"abstract":"<p><strong>Purpose: </strong>People with cancer routinely seek information and support in peer groups online. While peer communities constitute a major component of the health care landscape, they exist in isolation from clinical and research institutions. This study aimed to explore how and why cancer patients utilize online peer support groups and how they might be improved.</p><p><strong>Methods: </strong>A convenience sample of members of 6 closed Facebook cancer peer support groups (n=291) participated in an online needs assessment survey. We further conducted semi-structured interviews with 14 members and 6 moderator-patients, hand-coding the free-text responses and interview transcripts.</p><p><strong>Results: </strong>Group participation was largely motivated by the desire to exchange information (79%) and to connect with others sharing the same condition (76%). Among study participants, 40% indicated they did not get information or support from any other online or offline organizations, 60% indicated they had few concerns with Facebook peer support groups, 84% indicated it was at least somewhat important that their health information and posts remain private, and 75% desired more input from experts in order to access evidence-based information and curb misinformation. About half wanted more group moderation, and moderators themselves expressed an urgent need for training and support.</p><p><strong>Conclusions: </strong>While online peer groups are a commonly utilized care component for many people with cancer or hereditary cancer risk and serve as a primary source of condition information, many participants desired more expert involvement in and moderation of groups. Privacy and security of health information was another key need expressed.</p>","PeriodicalId":16724,"journal":{"name":"Journal of Patient-Centered Research and Reviews","volume":"10 2","pages":"58-67"},"PeriodicalIF":1.7,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10117532/pdf/jpcrr-10.2.58.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9387746","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Calcium Carbonate as a Potential Intervention to Prevent Labor Dystocia: Narrative Review of the Literature. 碳酸钙作为预防难产的潜在干预措施:文献综述。
IF 1.7 Q3 HEALTH CARE SCIENCES & SERVICES Pub Date : 2023-01-01 DOI: 10.17294/2330-0698.2010
Sabahat Raees, Marie Forgie, Rita Mitchell, Emily Malloy

Anecdotally, there are attestations from clinicians of calcium carbonate being used successfully for laboring people experiencing labor dystocia. The goal of this narrative review was to provide a synopsis of pertinent literature on calcium use in obstetrics to explore the potential benefit of calcium carbonate as a simple and low-cost intervention for prevention or treatment of labor dystocia. To answer how calcium and carbonate physiologically contribute to myometrium contractility, we conducted a literature search of English-language peer-reviewed articles, with no year limitation, consisting of the keywords "calcium," "calcium carbonate," "calcium gluconate," "pregnancy," "hemorrhage," and variations of "smooth muscle contractility" and "uterine contractions." Though no overt evidence on calcium carbonate's ability to prevent labor dystocia was identified; relevant information was found regarding smooth muscle contractility, calcium's influence on uterine muscle contractility, and carbonate's potential impact on reducing amniotic fluid lactate levels to restore uterine contractility during labor. Studies reporting the potential effectiveness of calcium gluconate and sodium bicarbonate in preventing labor dystocia offer background, safety information, and rationale for a future randomized control trial to evaluate the ability of calcium carbonate to prevent labor dystocia and reduce rates of cesarean section.

有趣的是,有临床医生证明碳酸钙被成功地用于劳动人民经历难产。这篇叙述性综述的目的是提供有关钙在产科应用的相关文献摘要,以探讨碳酸钙作为一种简单和低成本的干预措施预防或治疗难产的潜在益处。为了回答钙和碳酸钙在生理上如何促进肌层收缩,我们对英文同行评审的文章进行了文献检索,没有年份限制,包括关键词“钙”、“碳酸钙”、“葡萄糖酸钙”、“怀孕”、“出血”以及“平滑肌收缩”和“子宫收缩”的变化。虽然没有明确的证据表明碳酸钙能够预防难产;我们发现了平滑肌收缩力、钙对子宫肌肉收缩力的影响以及碳酸盐对降低羊水乳酸水平以恢复分娩时子宫收缩力的潜在影响。研究报告了葡萄糖酸钙和碳酸氢钠预防难产的潜在有效性,为未来评估碳酸钙预防难产和降低剖宫产率的随机对照试验提供了背景、安全信息和基本原理。
{"title":"Calcium Carbonate as a Potential Intervention to Prevent Labor Dystocia: Narrative Review of the Literature.","authors":"Sabahat Raees,&nbsp;Marie Forgie,&nbsp;Rita Mitchell,&nbsp;Emily Malloy","doi":"10.17294/2330-0698.2010","DOIUrl":"https://doi.org/10.17294/2330-0698.2010","url":null,"abstract":"<p><p>Anecdotally, there are attestations from clinicians of calcium carbonate being used successfully for laboring people experiencing labor dystocia. The goal of this narrative review was to provide a synopsis of pertinent literature on calcium use in obstetrics to explore the potential benefit of calcium carbonate as a simple and low-cost intervention for prevention or treatment of labor dystocia. To answer how calcium and carbonate physiologically contribute to myometrium contractility, we conducted a literature search of English-language peer-reviewed articles, with no year limitation, consisting of the keywords \"calcium,\" \"calcium carbonate,\" \"calcium gluconate,\" \"pregnancy,\" \"hemorrhage,\" and variations of \"smooth muscle contractility\" and \"uterine contractions.\" Though no overt evidence on calcium carbonate's ability to prevent labor dystocia was identified; relevant information was found regarding smooth muscle contractility, calcium's influence on uterine muscle contractility, and carbonate's potential impact on reducing amniotic fluid lactate levels to restore uterine contractility during labor. Studies reporting the potential effectiveness of calcium gluconate and sodium bicarbonate in preventing labor dystocia offer background, safety information, and rationale for a future randomized control trial to evaluate the ability of calcium carbonate to prevent labor dystocia and reduce rates of cesarean section.</p>","PeriodicalId":16724,"journal":{"name":"Journal of Patient-Centered Research and Reviews","volume":"10 3","pages":"128-135"},"PeriodicalIF":1.7,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10358971/pdf/jpcrr-10.3.128.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10240551","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Chewed Versus Swallowed Ticagrelor in P2Y12 Inhibitor-Naïve Patients Undergoing Percutaneous Coronary Intervention. 咀嚼与吞咽替格瑞洛在P2Y12 Inhibitor-Naïve经皮冠状动脉介入治疗患者中的作用。
IF 1.7 Q3 HEALTH CARE SCIENCES & SERVICES Pub Date : 2023-01-01 DOI: 10.17294/2330-0698.2009
Thomas F Wilson, Muddasir Ashraf, M Fuad Jan, Tonga Nfor, Louie Kostopoulos, Joaquin Solis, Jayant Khitha, Ahmad Khraisat, Anthony C DeFranco, Tanvir Bajwa, Suhail Q Allaqaband

Purpose: Dual antiplatelet therapy is standard for patients undergoing percutaneous coronary intervention (PCI) with stents. Traditionally, patients swallow the loading dose of a P2Y12 inhibitor before or during PCI. Time to achieve adequate platelet inhibition after swallowing the loading dose varies significantly. Chewed tablets may allow more rapid inhibition of platelet aggregation. However, data for this strategy in patients with stable ischemic heart disease or non-ST-elevation acute coronary syndrome (NSTE-ACS) are less robust.

Methods: In this single-center prospective trial, 112 P2Y12-naïve patients with stable ischemic heart disease or NSTE-ACS on aspirin therapy and who received ticagrelor after coronary angiography but before PCI were randomized to chewing (n=55) or swallowing (n=57) the ticagrelor loading dose (180 mg). Baseline variables were compared using 2-sample t-test and chi-squared/Fisher's exact tests as appropriate, with alpha set at 0.05. P2Y12 reaction units (PRU) were compared at baseline, 1 hour, and 4 hours using Wilcoxon rank-sum test. Patients then received standard ticagrelor dosing.

Results: After exclusions, P2Y12 PRU in the chewed and swallowed groups at baseline, 1 hour, and 4 hours after ticagrelor loading dose were 243 vs 256 (P=0.75), 143 vs 210 (P=0.09), and 28 vs 25 (P=0.89), respectively. No differences were found in major adverse cardiac events (MACE) or major bleeding at 30 days and 1 year.

Conclusions: In patients with stable ischemic heart disease or NSTE-ACS, chewing rather than swallowing ticagrelor may lead to slightly faster inhibition of platelet aggregation at 1 hour with no increase in MACE or major bleeding.

目的:双重抗血小板治疗是经皮冠状动脉介入治疗(PCI)的标准治疗方法。传统上,患者在PCI之前或期间吞下P2Y12抑制剂的负荷剂量。吞咽负荷剂量后达到充分血小板抑制的时间差异很大。咀嚼片剂可以更快地抑制血小板聚集。然而,该策略在稳定性缺血性心脏病或非st段抬高急性冠状动脉综合征(NSTE-ACS)患者中的应用数据不太可靠。方法:在这项单中心前瞻性试验中,112例P2Y12-naïve接受阿司匹林治疗的稳定型缺血性心脏病或NSTE-ACS患者,在冠状动脉造影后但PCI前接受替格瑞洛治疗,随机分为咀嚼组(n=55)和吞咽组(n=57),替格瑞洛负荷剂量(180 mg)。基线变量比较采用两样本t检验和适当的卡方/Fisher精确检验,α集为0.05。采用Wilcoxon秩和检验比较基线、1小时和4小时P2Y12反应单位(PRU)。然后患者接受标准替格瑞洛剂量。结果:排除后,咀嚼组和吞咽组在替格瑞洛加载剂量后基线、1小时和4小时的P2Y12 PRU分别为243 vs 256 (P=0.75)、143 vs 210 (P=0.09)和28 vs 25 (P=0.89)。在30天和1年的主要不良心脏事件(MACE)或大出血方面没有发现差异。结论:在稳定性缺血性心脏病或NSTE-ACS患者中,咀嚼而不是吞咽替格瑞洛可能导致1小时血小板聚集的抑制略快,而MACE或大出血未增加。
{"title":"Chewed Versus Swallowed Ticagrelor in P2Y12 Inhibitor-Naïve Patients Undergoing Percutaneous Coronary Intervention.","authors":"Thomas F Wilson,&nbsp;Muddasir Ashraf,&nbsp;M Fuad Jan,&nbsp;Tonga Nfor,&nbsp;Louie Kostopoulos,&nbsp;Joaquin Solis,&nbsp;Jayant Khitha,&nbsp;Ahmad Khraisat,&nbsp;Anthony C DeFranco,&nbsp;Tanvir Bajwa,&nbsp;Suhail Q Allaqaband","doi":"10.17294/2330-0698.2009","DOIUrl":"https://doi.org/10.17294/2330-0698.2009","url":null,"abstract":"<p><strong>Purpose: </strong>Dual antiplatelet therapy is standard for patients undergoing percutaneous coronary intervention (PCI) with stents. Traditionally, patients swallow the loading dose of a P2Y12 inhibitor before or during PCI. Time to achieve adequate platelet inhibition after swallowing the loading dose varies significantly. Chewed tablets may allow more rapid inhibition of platelet aggregation. However, data for this strategy in patients with stable ischemic heart disease or non-ST-elevation acute coronary syndrome (NSTE-ACS) are less robust.</p><p><strong>Methods: </strong>In this single-center prospective trial, 112 P2Y12-naïve patients with stable ischemic heart disease or NSTE-ACS on aspirin therapy and who received ticagrelor after coronary angiography but before PCI were randomized to chewing (n=55) or swallowing (n=57) the ticagrelor loading dose (180 mg). Baseline variables were compared using 2-sample <i>t</i>-test and chi-squared/Fisher's exact tests as appropriate, with alpha set at 0.05. P2Y12 reaction units (PRU) were compared at baseline, 1 hour, and 4 hours using Wilcoxon rank-sum test. Patients then received standard ticagrelor dosing.</p><p><strong>Results: </strong>After exclusions, P2Y12 PRU in the chewed and swallowed groups at baseline, 1 hour, and 4 hours after ticagrelor loading dose were 243 vs 256 (P=0.75), 143 vs 210 (P=0.09), and 28 vs 25 (P=0.89), respectively. No differences were found in major adverse cardiac events (MACE) or major bleeding at 30 days and 1 year.</p><p><strong>Conclusions: </strong>In patients with stable ischemic heart disease or NSTE-ACS, chewing rather than swallowing ticagrelor may lead to slightly faster inhibition of platelet aggregation at 1 hour with no increase in MACE or major bleeding.</p>","PeriodicalId":16724,"journal":{"name":"Journal of Patient-Centered Research and Reviews","volume":"10 2","pages":"50-57"},"PeriodicalIF":1.7,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10117533/pdf/jpcrr-10.2.50.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9381854","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of Perioperative Dexamethasone on Hospital Length of Stay and Glycemic Control in Patients With Type 2 Diabetes Undergoing Total Hip Arthroplasty. 地塞米松对2型糖尿病全髋关节置换术患者住院时间和血糖控制的影响
IF 1.7 Q3 HEALTH CARE SCIENCES & SERVICES Pub Date : 2023-01-01 DOI: 10.17294/2330-0698.1971
Vanessa Williams, Mohammad J Uddin Ansari, Amruta Jaju, Stacey Ward, Daniel O'Keefe, Jumana Abdelkarim, Nicole Montes, Ula Tarabichi, Albert Botchway, Michael G Jakoby

Purpose: This study aimed to evaluate effects of perioperative dexamethasone on hospital length of stay (LOS) and glycemic control for patients with type 2 diabetes mellitus undergoing total hip arthroplasty (THA).

Methods: We performed retrospective case review of THA performed in adults (≥18 years old) with type 2 diabetes at Springfield Memorial Hospital (Springfield, IL) immediately before (2013), during (2014), and after (2015) publication of consensus guidelines for use of perioperative dexamethasone. Hospital LOS was the primary endpoint. Capillary blood glucose by hospital day, proportion of patients treated with insulin, and median insulin dose by hospital day were secondary endpoints.

Results: A total of 209 patients were included: 109 not dosed with dexamethasone ("no dexamethasone"), and 100 treated with perioperative dexamethasone. The most common dose of dexamethasone was 4 mg (63% of patients). Mean (95% CI) reduction in adjusted hospital LOS for dexamethasone-treated patients, compared to controls, was -2.8 (-3.7 to -1.9) days for all patients, -1.6 (-2.7 to -0.5) days for those with arthritis as the indication for THA, and -4.0 (-5.9 to -2.1) days for those with fracture as indication for THA (P<0.001 for all). Glycemic control measured by median capillary blood glucose was no different or slightly better in the dexamethasone group than the no dexamethasone group, except for postoperative day 1 among patients treated with insulin prior to surgery.

Conclusions: Perioperative dexamethasone significantly reduces hospital LOS for patients with type 2 diabetes undergoing THA, with modest effects on hyperglycemia.

目的:本研究旨在评价地塞米松对2型糖尿病患者全髋关节置换术(THA)围手术期住院时间(LOS)和血糖控制的影响。方法:我们对在Springfield纪念医院(Springfield, IL)接受2型糖尿病成人(≥18岁)THA治疗的病例进行回顾性分析,这些患者在(2013年)、(2014年)和(2015年)发表地塞米松围手术期使用共识指南之前、期间和之后接受THA治疗。医院LOS是主要终点。住院日的毛细血管血糖、接受胰岛素治疗的患者比例和住院日的中位胰岛素剂量是次要终点。结果:共纳入209例患者:109例未使用地塞米松(“未使用地塞米松”),100例围手术期使用地塞米松。地塞米松最常见的剂量为4mg(63%的患者)。与对照组相比,地塞米松治疗的患者调整后的医院LOS平均(95% CI)减少为:所有患者-2.8(-3.7至-1.9)天,关节炎患者-1.6(-2.7至-0.5)天,骨折患者-4.0(-5.9至-2.1)天(pp结论:围手术期地塞米松可显著降低2型糖尿病患者接受THA的医院LOS,对高血糖的影响较小)。
{"title":"Impact of Perioperative Dexamethasone on Hospital Length of Stay and Glycemic Control in Patients With Type 2 Diabetes Undergoing Total Hip Arthroplasty.","authors":"Vanessa Williams,&nbsp;Mohammad J Uddin Ansari,&nbsp;Amruta Jaju,&nbsp;Stacey Ward,&nbsp;Daniel O'Keefe,&nbsp;Jumana Abdelkarim,&nbsp;Nicole Montes,&nbsp;Ula Tarabichi,&nbsp;Albert Botchway,&nbsp;Michael G Jakoby","doi":"10.17294/2330-0698.1971","DOIUrl":"https://doi.org/10.17294/2330-0698.1971","url":null,"abstract":"<p><strong>Purpose: </strong>This study aimed to evaluate effects of perioperative dexamethasone on hospital length of stay (LOS) and glycemic control for patients with type 2 diabetes mellitus undergoing total hip arthroplasty (THA).</p><p><strong>Methods: </strong>We performed retrospective case review of THA performed in adults (≥18 years old) with type 2 diabetes at Springfield Memorial Hospital (Springfield, IL) immediately before (2013), during (2014), and after (2015) publication of consensus guidelines for use of perioperative dexamethasone. Hospital LOS was the primary endpoint. Capillary blood glucose by hospital day, proportion of patients treated with insulin, and median insulin dose by hospital day were secondary endpoints.</p><p><strong>Results: </strong>A total of 209 patients were included: 109 not dosed with dexamethasone (\"no dexamethasone\"), and 100 treated with perioperative dexamethasone. The most common dose of dexamethasone was 4 mg (63% of patients). Mean (95% CI) reduction in adjusted hospital LOS for dexamethasone-treated patients, compared to controls, was -2.8 (-3.7 to -1.9) days for all patients, -1.6 (-2.7 to -0.5) days for those with arthritis as the indication for THA, and -4.0 (-5.9 to -2.1) days for those with fracture as indication for THA (P<0.001 for all). Glycemic control measured by median capillary blood glucose was no different or slightly better in the dexamethasone group than the no dexamethasone group, except for postoperative day 1 among patients treated with insulin prior to surgery.</p><p><strong>Conclusions: </strong>Perioperative dexamethasone significantly reduces hospital LOS for patients with type 2 diabetes undergoing THA, with modest effects on hyperglycemia.</p>","PeriodicalId":16724,"journal":{"name":"Journal of Patient-Centered Research and Reviews","volume":"10 1","pages":"4-12"},"PeriodicalIF":1.7,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9851389/pdf/jpcrr-10.1.4.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10586692","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Identifying Patient Perceptions of Inequality in Public Health Care Services: Evidence From a Single Indian Administrative District. 确定患者对公共卫生保健服务不平等的看法:来自单一印度行政区的证据。
IF 1.7 Q3 HEALTH CARE SCIENCES & SERVICES Pub Date : 2023-01-01 DOI: 10.17294/2330-0698.2013
Barnali Biswas, Piyal Basu Roy

Purpose: Assessment of patient experiences is an essential step to revamp patient-centered care and identify systemic effectiveness as part of universal health coverage. This paper analyzes the variation of health care at different levels of the public health care system in India by measuring patients' experience with the care they have received in the Alipurduar district of India.

Methods: From May 2021 to April 2022, stratified sampling technique was applied to collect primary data from 450 patients having different health problems from different levels of the public health care system. In addition, Consumer Assessment of Healthcare Providers and Systems (CAHPS) survey results were used to evaluate patient experience, with the reliability of questions measured by Cronbach's alpha. Collected data were categorized with the help of exploratory factor analysis; after which, analysis of variance and post-hoc tests were applied to understand specific variations in patient experiences.

Results: This study identified that the services delivered in the health centers were not suitable (6.160 out of 10) to fulfill the needs of the patients. Among the three domains of health care services - namely, proficiency, tangibility, and information - the experience of patients significantly varied (P<0.001) when comparing primary, secondary, and tertiary levels of the public health care system.

Conclusions: Patients receiving services from the centers under the tertiary level have expressed lesser satisfaction than those patients who have received care at primary or secondary levels because of excessive patient load, inadequate manpower, and other infrastructure deficits at the tertiary level.

目的:评估患者经验是改革以患者为中心的护理和确定作为全民健康覆盖一部分的系统有效性的重要步骤。本文通过测量患者在印度Alipurduar地区获得的护理经验,分析了印度不同级别公共卫生保健系统的医疗保健差异。方法:于2021年5月至2022年4月,采用分层抽样方法,收集来自不同层次公共卫生系统的450例不同健康问题患者的原始资料。此外,使用消费者对医疗服务提供者和系统的评估(CAHPS)调查结果来评估患者体验,并使用Cronbach's alpha测量问题的可靠性。利用探索性因子分析对收集到的数据进行分类;之后,应用方差分析和事后检验来了解患者经历的具体变化。结果:本研究发现,卫生中心提供的服务不适合满足患者的需求(6.160 / 10)。在卫生保健服务的三个领域中,即熟练程度、有形性和信息,患者的体验差异显著(p结论:由于患者负荷过重、人力不足和三级其他基础设施不足,从三级以下中心接受服务的患者表达的满意度低于接受初级或二级中心服务的患者。
{"title":"Identifying Patient Perceptions of Inequality in Public Health Care Services: Evidence From a Single Indian Administrative District.","authors":"Barnali Biswas,&nbsp;Piyal Basu Roy","doi":"10.17294/2330-0698.2013","DOIUrl":"https://doi.org/10.17294/2330-0698.2013","url":null,"abstract":"<p><strong>Purpose: </strong>Assessment of patient experiences is an essential step to revamp patient-centered care and identify systemic effectiveness as part of universal health coverage. This paper analyzes the variation of health care at different levels of the public health care system in India by measuring patients' experience with the care they have received in the Alipurduar district of India.</p><p><strong>Methods: </strong>From May 2021 to April 2022, stratified sampling technique was applied to collect primary data from 450 patients having different health problems from different levels of the public health care system. In addition, Consumer Assessment of Healthcare Providers and Systems (CAHPS) survey results were used to evaluate patient experience, with the reliability of questions measured by Cronbach's alpha. Collected data were categorized with the help of exploratory factor analysis; after which, analysis of variance and post-hoc tests were applied to understand specific variations in patient experiences.</p><p><strong>Results: </strong>This study identified that the services delivered in the health centers were not suitable (6.160 out of 10) to fulfill the needs of the patients. Among the three domains of health care services - namely, proficiency, tangibility, and information - the experience of patients significantly varied (P<0.001) when comparing primary, secondary, and tertiary levels of the public health care system.</p><p><strong>Conclusions: </strong>Patients receiving services from the centers under the tertiary level have expressed lesser satisfaction than those patients who have received care at primary or secondary levels because of excessive patient load, inadequate manpower, and other infrastructure deficits at the tertiary level.</p>","PeriodicalId":16724,"journal":{"name":"Journal of Patient-Centered Research and Reviews","volume":"10 3","pages":"121-127"},"PeriodicalIF":1.7,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10358969/pdf/jpcrr-10.3.121.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9860892","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Patient-Centered Research and Reviews
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1